Department of Transfusion Medicine and Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Br J Haematol. 2014 Apr;165(1):3-16. doi: 10.1111/bjh.12747. Epub 2014 Jan 25.
Red blood cells (RBCs) degrade progressively during the weeks of refrigerated storage. No universally accepted definition of 'fresh' or 'old' RBCs exists. While practices vary from country to country, preservative solutions permitting shelf life as long as 7 weeks have been licenced. Transfusion of stored RBCs, particularly those at the end of the approved shelf life, has been implicated in adverse clinical outcomes. The results of observational analyses, animal models and studies in volunteers have proved provocative, controversial and contradictory. A recently completed randomized controlled trial (RCT) in premature infants exemplifies the difficulties with moderately sized clinical studies. Several other RCTs are in progress. The effect of RBC storage may well vary according to the clinical setting. Resolution of the importance of the storage lesion may require large pragmatic clinical trials. In the meantime, institutions involved in blood collection and transfusion should explore strategies that assure blood availability, while limiting the use of the oldest RBCs currently approved by regulation.
红细胞(RBC)在冷藏储存的数周内逐渐降解。目前尚无普遍接受的“新鲜”或“陈旧”RBC 的定义。虽然各国的做法有所不同,但已获得许可的保存液可使 RBC 的保质期长达 7 周。输注储存的 RBC,特别是在批准的保质期结束时,与不良临床结局有关。观察性分析、动物模型和志愿者研究的结果具有启发性、争议性和矛盾性。最近一项早产儿的随机对照试验(RCT)说明了中等规模临床研究的困难。还有其他几项 RCT 正在进行中。RBC 储存的效果可能因临床环境而异。解决储存损伤的重要性可能需要进行大规模的实用临床试验。在此期间,参与采血和输血的机构应探索既能确保血液供应,又能限制使用目前按规定批准的最陈旧 RBC 的策略。